Sudarshan Pharma Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/10/2025 ,inter alia, to consider and approve Unaudited Standalone ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sudarshan Pharma Industries has informed BSE that its Board of Directors will meet on Saturday, 18th October 2025. The main agenda is to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th September 2025. The company has also notified that the trading window for insiders will remain closed until 48 hours after the results are declared. This is a routine compliance filing under SEBI LODR Regulations, 2015, and no actual financial numbers have been disclosed yet.
This is a standard pre-results intimation and does not contain any financial data. Investors should watch for the actual Q2 FY26 results on 18th October 2025, which will provide the first real signal on the company's quarterly performance. Until then, the stock is in a quiet period with no insider trading allowed.